Kohl Thomas, Riehle Nadja, Messroghli Leila, Maus Sibylle, Otto Christiane, Klinke Michaela, Martel Richard, Beck Grietje, Boettcher Michael, Schaible Thomas
Deutsches Zentrum für Fetalchirurgie & Minimal-Invasive Therapie (DZFT), Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.
Department of Anesthesiology, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.
Children (Basel). 2023 Oct 30;10(11):1758. doi: 10.3390/children10111758.
The purpose of this report is to describe the seminal case of a near-term human fetus with a life-threatening left diaphragmatic hernia that underwent fetoscopic tracheal occlusion (FETO) combined with fetoscopic partial removal of herniated bowel from the fetal chest by fetoscopic laparoschisis (FETO-LAP).
A life-threatening left diaphragmatic hernia (liver-up; o/e LHR of ≤25%; MRI lung volume ≤ 20%) was observed in a human fetus at 34 weeks of gestation. After counselling the mother about the high risks of postnatal demise if left untreated, the expected limitations of fetoscopic tracheal occlusion (FETO), and the previously untested option of combining FETO with fetoscopic laparoschisis, i.e., partial removal of the herniated bowel from the fetal chest (FETO-LAP), she consented to the latter novel treatment approach. FETO-LAP was performed at 36 + 5 weeks of gestation under general maternofetal anesthesia. Mother and fetus tolerated the procedure well. The neonate was delivered and the balloon removed on placental support at 37 + 2 weeks of gestation. On ECMO, a rapid increase in tidal volume was seen over the next eight days. Unfortunately, after this period, blood clots obstructed the ECMO circuit and the neonate passed away.
This seminal case shows that in a fetus with severe left diaphragmatic hernia, partial removal of the herniated organs from the fetal chest is not only possible by minimally invasive fetoscopic techniques but also well tolerated. As the effect of FETO alone is limited in saving severely affected fetuses, combining FETO with fetoscopic laparoschisis (FETO-LAP) offers a new therapeutic route with multiple, potentially life-saving implications.
本报告旨在描述一例孕晚期人类胎儿的典型病例,该胎儿患有危及生命的左侧膈疝,接受了胎儿镜下气管阻塞术(FETO),并通过胎儿镜下剖腹术(FETO-LAP)从胎儿胸腔中部分取出疝入的肠管。
在一名妊娠34周的人类胎儿中观察到危及生命的左侧膈疝(肝脏上移;超声心动图检查显示左心室射血分数≤25%;MRI肺容积≤20%)。在向母亲咨询了若不治疗产后死亡的高风险、胎儿镜下气管阻塞术(FETO)的预期局限性以及将FETO与胎儿镜下剖腹术相结合(即从胎儿胸腔中部分取出疝入的肠管,FETO-LAP)这一此前未经测试的选择后,她同意了这种新的治疗方法。FETO-LAP在妊娠36 + 5周时在全身母婴麻醉下进行。母亲和胎儿对该手术耐受性良好。新生儿在妊娠37 + 2周时分娩,并在胎盘支持下取出球囊。在体外膜肺氧合(ECMO)支持下,在接下来的八天里潮气量迅速增加。不幸的是,在此之后,血凝块阻塞了ECMO回路,新生儿死亡。
这个典型病例表明,对于患有严重左侧膈疝的胎儿,通过微创胎儿镜技术不仅可以从胎儿胸腔中部分取出疝入的器官,而且耐受性良好。由于单独的FETO在挽救严重受影响胎儿方面的效果有限,将FETO与胎儿镜下剖腹术(FETO-LAP)相结合提供了一条新的治疗途径,具有多种潜在的挽救生命的意义。